1188PClinical and immune effects patients with progressive...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1188PClinical and immune effects patients with progressive disease treated with low dose of anti-CTLA-4, bortezomib, gemcitabine, naproxen and meloxicam

Marquez-Manriquez, J.P., Briseno, J.A.M., Quayle, K., Fernandez, L.M., Barajas, I.R., Torres-Montano, G., Durazo-Bustamante, F.A., Durazo-Acuna, A., Rangel-Reyna, L-A., Lopez-Hernandez, D., Rodriguez-
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx376.053
Date:
September, 2017
File:
PDF, 46 KB
english, 2017
Conversion to is in progress
Conversion to is failed